746 AFM24 and atezolizumab combination in patients with advanced epidermal growth factor receptor-expressing (EGFR+) solid tumors: Initial results from the phase 1 dose-escalation study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.